{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:09:55Z","timestamp":1793650195749,"version":"4.5.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":5479,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2000,12]]},"DOI":"10.1046\/j.1523-1747.2000.00156.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T05:56:15Z","timestamp":1047448575000},"page":"1059-1064","source":"Crossref","is-referenced-by-count":59,"title":["Elimination of CD4+ T Cells Enhances Anti-Tumor Effect of Locally Secreted Interleukin-12 on B16 Mouse Melanoma and Induces Vitiligo-Like Coat Color Alteration"],"prefix":"10.1016","volume":"115","author":[{"given":"Hiroshi","family":"Nagai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Horikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamitsu","family":"Ichihashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadao","family":"Kamidono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0010","first-page":"2191","article-title":"Anti-tumor effects of granulocyte-macrophage colony-stimulating factor production by melanoma cells","volume":"56","author":"Armstrong","year":"1996","journal-title":"Cancer Res"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0015","doi-asserted-by":"crossref","first-page":"963","DOI":"10.4049\/jimmunol.138.3.963","article-title":"Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo","volume":"138","author":"Asher","year":"1987","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0020","first-page":"87","article-title":"Cyclophosphamide (Cy) -facilitated adoptive immunotherapy of a Cy-resistant tumour. Evidence that Cy permits the expression of adoptive T-cell mediated immunity by removing supressor T cells rather than by reducing tumour burden","volume":"65","author":"Awwad","year":"1988","journal-title":"Immunology"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0025","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1084\/jem.168.6.2193","article-title":"Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. A consequence of removing L3T4+ suppressor T cells from a host generating predominantly Lyt-2+ T cell-mediated immunity","volume":"168","author":"Awwad","year":"1988","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0030","first-page":"2228","article-title":"Radiosensitive barrier to T-cell-mediated adoptive immunotherapy of established tumors","volume":"50","author":"Awwad","year":"1990","journal-title":"Cancer Res"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0035","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/jlb.55.2.280","article-title":"Interleukin-12","volume":"55","author":"Brunda","year":"1994","journal-title":"J Leukoc Biol"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0040","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1084\/jem.178.4.1223","article-title":"Anti-tumor and antimetastatic activity of interleukin12 against murine tumors","volume":"178","author":"Brunda","year":"1993","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0045","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0738-081X(89)90063-1","article-title":"Serum antibodies in vitiligo patients","volume":"7","author":"Bystryn","year":"1989","journal-title":"Clin Dermatol"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0050","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/archderm.1987.01660320095019","article-title":"The prognostic significance of hypopigmentation in malignant melanoma","volume":"123","author":"Bystryn","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0055","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.4049\/jimmunol.138.11.3688","article-title":"Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones","volume":"138","author":"Cher","year":"1987","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0060","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","article-title":"Single-step method of RNA isolation by guanidium thiocyanate-chloroform extraction","volume":"162","author":"Chomczynski","year":"1987","journal-title":"Anal Biochem"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0065","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.4049\/jimmunol.140.8.2853","article-title":"Adoptive immunotherapy of syngeneic murine leukemia is enhanced by the combination of recombinant IFN-gamma and a tumor-specific cytotoxic T cell clone","volume":"140","author":"De Graaf","year":"1988","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0070","first-page":"771","article-title":"Uveitis and vitiligo associated with BCG treatment for malignant melanoma","volume":"76","author":"Donaldson","year":"1974","journal-title":"Surgery"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0075","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1084\/jem.190.3.355","volume":"190","author":"van Elsas","year":"1999","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0080","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.4049\/jimmunol.158.5.2278","article-title":"Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization","volume":"158","author":"Feltquate","year":"1997","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0085","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1461::AID-CNCR3>3.0.CO;2-E","article-title":"Autoantibodies to tyrosinase: the bridge between melanoma and vitiligo","volume":"79","author":"Fishman","year":"1997","journal-title":"Cancer"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0090","series-title":"Modern nutrition in health and disease","article-title":"Measurement of human and mouse interleukin 12","volume":"Vol. 1","author":"Gately","year":"1992"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0095","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1126\/science.1948050","article-title":"Treatment of established renal cell cancer by tumor cells engineered to secrete interleukin-4","volume":"254","author":"Golumbek","year":"1991","journal-title":"Science"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0100","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ijc.2910610219","article-title":"Rejection of mouse melanoma elicited by local secretion of interleukin-2: implicating macrophages without T cells or natural killer cells in tumor rejection","volume":"61","author":"Hara","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0105","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1084\/jem.182.5.1609","article-title":"Implicating a role for immune recognition of self in tumor rejection: Passive immunization against the brown locus protein","volume":"182","author":"Hara","year":"1995","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0110","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/258731a0","article-title":"Effect of tumor necrosis factor on cultured human melanoma cells","volume":"258","author":"Helson","year":"1975","journal-title":"Nature"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0115","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/08830189709116851","article-title":"Immunobiology of human melanoma antigens MART-1 and gp100 and their use for immuno-gene therapy","volume":"14","author":"Kawakami","year":"1997","journal-title":"Int Rev Immunol"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0120","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1046\/j.1365-2133.1998.02503.x","article-title":"Autoantibodies to tyrosinase-related protein-1 detected in the sera of vitiligo patients using a quantitative radiobinding assay","volume":"139","author":"Kemp","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0125","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0039-6060(05)80054-6","article-title":"Immunoregulatory effects of CD4+ T helper subsets in human melanoma","volume":"117","author":"Lee","year":"1995","journal-title":"Surgery"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0130","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/eji.1830250124","article-title":"CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes","volume":"25","author":"Martinotti","year":"1995","journal-title":"Eur J Immunol"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0135","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0065-2776(08)60652-5","article-title":"Heterogeneity of cytokine secretion patterns and functions of helper T cells","volume":"46","author":"Mosmann","year":"1989","journal-title":"Adv Immunol"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0140","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0167-5699(96)80606-2","article-title":"The expanding universe of T-cell subsets: Th1, Th2 and more","volume":"17","author":"Mosmann","year":"1996","journal-title":"Immunol Today"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0145","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0190-9622(83)70182-9","article-title":"Vitiligo in patients with metastatic melanoma: a good prognostic sign","volume":"9","author":"Nordlund","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0150","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/1523-1747.ep12461505","article-title":"Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity","volume":"90","author":"Norris","year":"1988","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0155","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1084\/jem.164.5.1652","article-title":"Radiation-induced, immunologically-mediated regression of an established tumor as an example of successful therapeutic immunomanipulation. Preferential elimination of suppressor T cells allows sustained production of effector T cells","volume":"164","author":"North","year":"1986","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0160","first-page":"90","article-title":"Elimination of cycling CD4+ suppressor T cells with an antimitotic drug releases non-cycling CD8+ T cells to cause regression of an advanced lymphoma","volume":"71","author":"North","year":"1990","journal-title":"Immunology"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0165","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1084\/jem.159.5.1295","article-title":"Generation and decay of the immune response to a progressive fibrosarcoma. 1. Ly-1+2-supressor T cells down-regulate the generation of Ly-1\u20132+ effector T cells","volume":"159","author":"North","year":"1984","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0170","first-page":"47","article-title":"Ly-1+2-supressor T cells down-regulate the generation of Ly-1\u20132+ effector T cells during progressive growth of P815 mastocytoma","volume":"54","author":"North","year":"1985","journal-title":"Immunology"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0175","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1046\/j.1523-1747.1998.00411.x","article-title":"Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy","volume":"111","author":"Okamoto","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0180","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1128\/MCB.3.2.280","article-title":"A cDNA cloning vector that permits expression of cDNA inserts in mammalian cells","volume":"3","author":"Okayama","year":"1983","journal-title":"Mol Cell Biol"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0185","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1073\/pnas.96.6.2982","article-title":"Vaccination with a recombinant vaccinia virus encoding a \u2018\u2018self\u2019' antigen induce autoimmune vitiligo and tumor cell destruction in mice: Requirement for CD4+ T lymphocytes","volume":"96","author":"Overwijk","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0190","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.1128\/JVI.70.9.6119-6125.1996","article-title":"Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery","volume":"70","author":"Petmer","year":"1996","journal-title":"J Virol"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0195","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1002\/eji.1830231147","article-title":"Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo","volume":"23","author":"Powrie","year":"1993","journal-title":"Eur J Immunol"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0200","first-page":"107","article-title":"Elimination of CD4+ T cells in mice bearing an advanced sarcoma augments the anti-tumor action of interleukin-2","volume":"38","author":"Rakhmilevich","year":"1994","journal-title":"Cancer Immunol Immunother"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0205","series-title":"Molecular Cloning","first-page":"33","author":"Sambrook","year":"1982"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0210","doi-asserted-by":"crossref","first-page":"6650","DOI":"10.4049\/jimmunol.162.11.6650","article-title":"The tumorigenicity of IL-2 gene-transfected murine M-3D melanoma cells is determined by the magnitude and quality of the host defence reaction: natural killer cells play a major role","volume":"162","author":"Schneeberger","year":"1999","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0215","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1146\/annurev.iy.01.040183.001235","article-title":"Mechanisms of T cell\u2013B cell interaction","volume":"1","author":"Singer","year":"1983","journal-title":"Annu Rev Immunol"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0220","first-page":"327","article-title":"Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter","volume":"1","author":"Southern","year":"1982","journal-title":"J Mol Appl Genet"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0225","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/hum.1994.5.2-153","article-title":"Experimental and clinical studies of cytokine gene-modified tumor cells","volume":"5","author":"Tepper","year":"1994","journal-title":"Hum Gene Ther"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0230","first-page":"11","article-title":"In vivo cancer gene therapy with a recombinant interleukin-2 adenovirus vector","volume":"3","author":"Toloza","year":"1996","journal-title":"Cancer Gene Ther"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0235","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1182\/blood.V84.12.4008.bloodjournal84124008","article-title":"Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in generation of T-helper cells type1 and cytotoxic lymphocytes","volume":"84","author":"Trinchieri","year":"1994","journal-title":"Blood"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0240","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1084\/jem.183.3.1001","volume":"183","author":"Xu","year":"1996","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2000.00156.x_bb0245","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/ijc.2910410217","article-title":"Interferon-gamma treatment of B16 melanoma cells; opposing effects for non-adaptive and adaptive immune defense and its reflection by metastatic spread","volume":"41","author":"Zoller","year":"1988","journal-title":"Int J Cancer"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15410838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15410838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T18:45:03Z","timestamp":1682102703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15410838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2000,12]]}},"alternative-id":["S0022202X15410838"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-1747.2000.00156.x","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2000,12]]}}}